课题基金 / 基金详情

Liver transplantation in Baboons using 1,3-Galactosyltransferase gene-knockout pigs as donors

Liver transplantation in Baboons using 1,3-Galactosyltransferase gene-knockout pigs as donors
使用 1,3-半乳糖基转移酶基因敲除猪作为供体进行狒狒肝移植
批准号:
38826163
负责人:
Privatdozent Dr. Matthias Heuer, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2007
资助国家:
德国
项目状态:
已结题
起止时间:
2006-12-31 至 2007-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As organ shortage is increasing, xenotransplantation may become a potential alternative to increase the number of organs to be transplanted. The swine appears to be the most suitable xenograft donor, because of the similarity of many of its organ systems and physiologic parameters to those of humans. But when a swine organ is transplanted into a primate, hyperacute rejection, induced by a single epitope, galactosyl-alpha-1,3-galactose (Gal), develops rapidly. To avoid this problem, recently genetically-engineered swine, alpha- 1,3-galactosyltransferase knockout (GalT-KO) miniature swine, that do not express the Gal epitope for human natural antibodies were generated. Initial studies undertaken with GalTKO swine kidney, kidney/thymus and heart transplantation have shown promising long-term results. The purpose of this study is to develop a primate model for long-term metabolic and immunosuppressive monitoring of liver xenotransplants obtained from GalT-KO swine. Baboons will undergo pig-to-baboon xenotransplantation. Achieving long-term survival using either standard immunosuppression or a tolerance-inducing protocol, we will monitor physiologic, metabolic and immunologic parameters in the transplant recipient to characterize the function of the xenograft.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
  • 批准号:
    82371726
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    李文
  • 依托单位:
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李轶
  • 依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
  • 批准号:
    82371791
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘永波
  • 依托单位:
肝脏类器官的建立及其在移植治疗肝脏疾病中的研究